Dr. Josep Rodes-Cabau
Claim this profileIUCPQ
Affiliated Hospitals
IUCPQ
Institut Universitaire De Cardiologie Et De Pneumologie De Québec (IUCPQ)
Clinical Trials Josep Rodes-Cabau is currently running
Cephea Valve System
for Mitral Regurgitation
This trial is testing a new device called the Cephea Mitral Valve System that can fix or replace a damaged heart valve using a thin tube. It aims to help patients with mitral valve disease who need a less invasive treatment than open-heart surgery. The Cephea Mitral Valve System is a new technology developed by Cephea Valve Technologies, aiming to treat severe mitral regurgitation through a less invasive approach.
Recruiting
1 award
N/A
Valve Function Assessment After TAVR
for Aortic Valve Stenosis
This trial tests a new way to evaluate heart valve replacements in patients with small failing valves. It uses a minimally invasive procedure to place a new valve inside the old one and compares two methods of checking how well the new valve works.
Recruiting
1 award
N/A
3 criteria
More about Josep Rodes-Cabau
Clinical Trial Related
6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Josep Rodes-Cabau has experience with
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
- Transcatheter Aortic Valve Replacement
- Antiplatelet Treatment Discontinuation
- Cardiostat
- Edwards
Breakdown of trials Josep Rodes-Cabau has run
Aortic Valve Stenosis
Von Willebrand Disease
Transcatheter Aortic Valve Replacement
- Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR
- Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: a Prospective Registry with Central Echocardiography Analysis.
- The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures
Aortic Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Josep Rodes-Cabau specialize in?
Josep Rodes-Cabau focuses on Aortic Valve Stenosis and Von Willebrand Disease. In particular, much of their work with Aortic Valve Stenosis has involved treating patients, or patients who are undergoing treatment.
Is Josep Rodes-Cabau currently recruiting for clinical trials?
Yes, Josep Rodes-Cabau is currently recruiting for 4 clinical trials in Quebec City Quebec. If you're interested in participating, you should apply.
Are there any treatments that Josep Rodes-Cabau has studied deeply?
Yes, Josep Rodes-Cabau has studied treatments such as Evolut FX TAVR System, Medtronic Evolut PRO+ TAVR System, Transcatheter Aortic Valve Replacement.
What is the best way to schedule an appointment with Josep Rodes-Cabau?
Apply for one of the trials that Josep Rodes-Cabau is conducting.
What is the office address of Josep Rodes-Cabau?
The office of Josep Rodes-Cabau is located at: Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec G1V 4G5 Canada. This is the address for their practice at the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.